FRANCISCO JAVIER
SALMERÓN ESCOBAR
Investigador en el periodo 2002-2020
Complejo Hospitalario Torrecárdenas de Almería
Almería, EspañaPublicaciones en colaboración con investigadores/as de Complejo Hospitalario Torrecárdenas de Almería (10)
2021
-
Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry
Journal of Hepatology, Vol. 75, Núm. 1, pp. 86-97
2020
2019
-
High efficacy of resistance-guided retreatment of HCV patients failing NS5A inhibitors in the real world
Journal of Hepatology, Vol. 71, Núm. 5, pp. 876-888
-
Prevalence of resistance associated substitutions and efficacy of baseline resistance-guided chronic hepatitis C treatment in Spain from the GEHEP-004 cohort
PLoS ONE, Vol. 14, Núm. 8
2015
-
Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis
World Journal of Gastroenterology, Vol. 21, Núm. 30, pp. 9163-9174
2009
-
Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex
Hepatology, Vol. 49, Núm. 6, pp. 2001-2009
2006
-
Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry
Hepatology, Vol. 44, Núm. 6, pp. 1581-1588
2005
-
Drug-induced liver injury: An analysis of 461 incidences submitted to the Spanish registry over a 10-year period
Gastroenterology, Vol. 129, Núm. 2, pp. 512-521
2004
-
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease
Hepatology, Vol. 39, Núm. 6, pp. 1603-1612
1999
-
Acute liver injury associated with the use of ebrotidine, a new H2- receptor antagonist
Journal of Hepatology, Vol. 31, Núm. 4, pp. 641-646